194 related articles for article (PubMed ID: 23475473)
21. 17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression.
Huang Q; Zhang Z; Liao Y; Liu C; Fan S; Wei X; Ai B; Xiong J
J Exp Clin Cancer Res; 2018 Jul; 37(1):133. PubMed ID: 29970138
[TBL] [Abstract][Full Text] [Related]
22. MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer.
Wang Z; Li Z; Wu C; Wang Y; Xia Y; Chen L; Zhu Q; Chen Y
Med Oncol; 2014 Jan; 31(1):790. PubMed ID: 24310811
[TBL] [Abstract][Full Text] [Related]
23. [Expression of estrogen receptors beta and beta1 in tissue of human non-small cell lung cancer].
Shaturova AS; Bogush TA; Dudko EA; Chemeris GIu; Ramanauskaĭte RIu; Kalganov ID
Antibiot Khimioter; 2012; 57(5-6):11-7. PubMed ID: 23156039
[TBL] [Abstract][Full Text] [Related]
24. Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progression.
Bai Y; Shen W; Zhang L; Yang Z; Xiong L; Tang H; Zhao J
Autoimmunity; 2018 Jun; 51(4):157-165. PubMed ID: 30022688
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.
Raso MG; Behrens C; Herynk MH; Liu S; Prudkin L; Ozburn NC; Woods DM; Tang X; Mehran RJ; Moran C; Lee JJ; Wistuba II
Clin Cancer Res; 2009 Sep; 15(17):5359-68. PubMed ID: 19706809
[TBL] [Abstract][Full Text] [Related]
27. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
28. The expression of ERβ2, Bcl-xl and Bax in non-small cell lung cancer and associated with prognosis.
Liu J; Nie Z; Lei Y; Yang S; Liu Z
Int J Clin Exp Pathol; 2017; 10(9):10040-10046. PubMed ID: 31966894
[TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of CD63 expressionin patients with non-small cell lung cancer.
Koh H; An H; Jung J; Song D
Pol J Pathol; 2019; 70(3):183-188. PubMed ID: 31820861
[TBL] [Abstract][Full Text] [Related]
30. CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression.
Yin X; Xia J; Sun Y; Zhang Z
BMC Pulm Med; 2020 Feb; 20(1):40. PubMed ID: 32054470
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptorβ2 regulates interlukin-12 receptorβ2 expression via p38 mitogen-activated protein kinase signaling and inhibits non-small-cell lung cancer proliferation and invasion.
Liu ZG; Jiao XY; Chen ZG; Feng K; Luo HH
Mol Med Rep; 2015 Jul; 12(1):248-54. PubMed ID: 25695486
[TBL] [Abstract][Full Text] [Related]
32. Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer.
Li XQ; Yang XL; Zhang G; Wu SP; Deng XB; Xiao SJ; Liu QZ; Yao KT; Xiao GH
J Transl Med; 2013 May; 11():114. PubMed ID: 23648139
[TBL] [Abstract][Full Text] [Related]
33. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).
Hötzel J; Melling N; Müller J; Polonski A; Wolters-Eisfeld G; Izbicki JR; Karstens KF; Tachezy M
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2285-2292. PubMed ID: 31372722
[TBL] [Abstract][Full Text] [Related]
34. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
35. Differential expression patterns of estrogen receptor (ER)-β splice variants between papillary thyroid cancer and nodular thyroid goiter.
Dong W; Li J; Huang Y; Zhang H; Shan Z; Teng W
Med Sci Monit; 2012 Sep; 18(9):BR351-5. PubMed ID: 22936184
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
[TBL] [Abstract][Full Text] [Related]
37. Association of cytoplasmic p27 expression with an unfavorable response to cisplatin-based chemotherapy and poor outcomes in non-small cell lung cancer.
Lin TC; Tsai LH; Chou MC; Chen CY; Lee H
Tumour Biol; 2016 Mar; 37(3):4017-23. PubMed ID: 26482622
[TBL] [Abstract][Full Text] [Related]
38. Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer.
Davies MP; O'Neill PA; Innes H; Sibson DR; Prime W; Holcombe C; Foster CS
J Mol Endocrinol; 2004 Dec; 33(3):773-82. PubMed ID: 15591034
[TBL] [Abstract][Full Text] [Related]
39. HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis.
Qian L; Ji AH; Zhang WJ; Zhao N
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):430-442. PubMed ID: 29424924
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs.
Xu JY; Lu S; Xu XY; Hu SL; Li B; Li WX; Chang JY
Tumour Biol; 2016 Aug; 37(8):10349-56. PubMed ID: 26846099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
